Skip to main content
. 2019 Jun 12;55(2):405–414. doi: 10.3892/ijo.2019.4824

Figure 1.

Figure 1

HCQ promotes the antitumor effects of BC001 in vitro. (A) HCQ inhibited BGC823 cell viability in a dose-dependent manner using a Cell Counting Kit-8 assay; (B) HCQ enhanced the anti-proliferative effects of BC001 on BGC823 cells as determined with a Real-time cell analyzer System. (C) HCQ promoted the apoptosis of BGC823 cells following BC001 treatment as determined by flow cytometry. (D) Apoptosis ratio of cells treated with HCQ and/or BC001. ***P<0.001 vs. CK. CK, control group; FITC, fluorescein isothiocyanate; HCQ, hydroxychloroquine; Imax, maximal inhibitory concentration; IC50 half-maximal inhibitory concentration.